| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,161 | 15,370 | 13,876 | 14,357 | | Cost of Revenue | 8,298 | 7,083 | 8,367 | 5,436 | | | Gross Profit | 7,863 | 8,287 | 5,509 | 8,921 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,499) | 4,093 |
-
| 3,199 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,653 | 1,601 | 1,598 | 1,720 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,850 | 2,593 | 3,911 | 4,002 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 295 | (90) | 577 | 125 | | Earnings Before Interest And Taxes | 4,145 | 3,586 | 3,405 | (340) | | Interest Expense | 2,033 | 1,589 | 1,798 | 1,851 | | Income Before Tax | 2,112 | 1,997 | 1,607 | (2,191) | | Income Tax Expense | 3,859 | (1,083) | 1,083 | 979 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,747) | 1,997 | 1,607 | 1,297 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,112 | 1,997 | 1,607 | 1,297 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,112 | $1,997 | $1,607 | $1,297 |
|
0.26% Nasdaq 
Income Statement
